- Home
- TNGX vs CCCS Comparison
TNGX vs CCCS Comparison
Compare TNGX & CCCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- CCCS
- Stock Information
- Founded
- TNGX 2014
- CCCS 1980
- Country
- TNGX United States
- CCCS United States
- Employees
- TNGX N/A
- CCCS N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- CCCS Computer Software: Prepackaged Software
- Sector
- TNGX Health Care
- CCCS Technology
- Exchange
- TNGX Nasdaq
- CCCS Nasdaq
- Market Cap
- TNGX 735.0M
- CCCS 7.0B
- IPO Year
- TNGX N/A
- CCCS N/A
- Fundamental
- Price
- TNGX $6.64
- CCCS $11.32
- Analyst Decision
- TNGX Strong Buy
- CCCS Buy
- Analyst Count
- TNGX 8
- CCCS 7
- Target Price
- TNGX $15.14
- CCCS $13.86
- AVG Volume (30 Days)
- TNGX 885.7K
- CCCS 2.3M
- Earning Date
- TNGX 11-06-2024
- CCCS 10-28-2024
- Dividend Yield
- TNGX N/A
- CCCS N/A
- EPS Growth
- TNGX N/A
- CCCS N/A
- EPS
- TNGX N/A
- CCCS 0.03
- Revenue
- TNGX $42,509,000.00
- CCCS $909,603,000.00
- Revenue This Year
- TNGX $18.15
- CCCS $11.07
- Revenue Next Year
- TNGX N/A
- CCCS $8.60
- P/E Ratio
- TNGX N/A
- CCCS $369.30
- Revenue Growth
- TNGX 26.16
- CCCS 11.00
- 52 Week Low
- TNGX $6.33
- CCCS $9.79
- 52 Week High
- TNGX $13.01
- CCCS $12.68
- Technical
- Relative Strength Index (RSI)
- TNGX 37.15
- CCCS 66.82
- Support Level
- TNGX $6.83
- CCCS $10.60
- Resistance Level
- TNGX $7.47
- CCCS $11.02
- Average True Range (ATR)
- TNGX 0.37
- CCCS 0.20
- MACD
- TNGX 0.11
- CCCS 0.06
- Stochastic Oscillator
- TNGX 27.31
- CCCS 94.00
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About CCCS CCC Intelligent Solutions Holdings Inc.
CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, and AI-enabled digital workflows. The company generate revenue through the sale of software subscriptions and other revenue, primarily from professional services. The company has its presence in United States and China. Majority of the revenue is generated from United States.